Full name
MEDILENS SPÓŁKA Z OGRANICZONĄ ODPOWEDZIALNOŚCIĄ
uses securityreCAPTCHA
MEDILENS
Kozia 3a, 25-514 Kielce
TAX ID9591813075
Rate company:
MEDILENS
TAX ID9591813075
Share capital1,202,200.00 zł
address
Kozia 3a, 25-514 Kielce
Categories
Main category
Register Data
NIP
9591813075
REGON
260218447
KRS
0000301882
Legal form
limited liability company
ALEO.com Registration Date
2013-12-02
Register Address
UL. KOZIA 3 A, 25-514 KIELCE
Date of registration in KRS
2008-03-19
Date of commencement of economic activity
2008-03-19
Act signature
RDF/618051/24/171
Pkd codes
86.10.Z - Hospital activities
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
68.10.Z - Buying and selling of own real estate
68.20.Z - Rental and operating of own or leased real estate
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
84.12.Z - Regulation of the activities of providing health care, education, cultural services and other social services, excluding social security
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
86.22.Z - Specialist medical practice activities
Payer VAT status
Active
Vat list bank account(s)
PL40 1130 1192 0027 6114 9620 0001 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | ||
|---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss)  | 0,8 | 1,2 | 45,6 |
EBITDA | 1,1 | 1,5 | 29,2 |
Short time liabilities | 0,7 | 0,6 | -19,6 |
Equity capital | 7 | 8,1 | 15,8 |
Operating profit (EBIT) | 0,8 | 1,2 | 45,6 |
Assets | 7,7 | 8,7 | 12,4 |
Net profit (loss) | 0,8 | 1,1 | 40,1 |
Cash | 2,6 | 2,7 | 4,5 |
Net income from sale | 5,3 | 5,9 | 12 |
Liabilities and provisions for liabilities | 0,7 | 0,6 | -19,6 |
Working assets | 2,9 | 3,2 | 8,8 |
Depreciation | 0,3 | 0,3 | -15,5 |
% | % | p.p. | |
Profitability of capital | 11,3 | 13,6 | 2,3 |
Equity capital to total assets | 90,5 | 93,2 | 2,7 |
Gross profit margin | 15,6 | 20,3 | 4,7 |
EBITDA Margin | 21,4 | 24,7 | 3,3 |
Days | Days | Days | |
Short term commitment turnover cycle | 51 | 36 | -15 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xades01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
